Dystrophin restoration therapy improves both the reduced excitability and the force drop induced by lengthening contractions in dystrophic mdx skeletal muscle

BACKGROUND: The greater susceptibility to contraction-induced skeletal muscle injury (fragility) is an important dystrophic feature and tool for testing preclinic dystrophin-based therapies for Duchenne muscular dystrophy. However, how these therapies reduce the muscle fragility is not clear. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Roy, Pauline, Rau, Fredérique, Ochala, Julien, Messéant, Julien, Fraysse, Bodvael, Lainé, Jeanne, Agbulut, Onnik, Butler-Browne, Gillian, Furling, Denis, Ferry, Arnaud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4952281/
https://www.ncbi.nlm.nih.gov/pubmed/27441081
http://dx.doi.org/10.1186/s13395-016-0096-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4952281/
https://www.ncbi.nlm.nih.gov/pubmed/27441081
http://dx.doi.org/10.1186/s13395-016-0096-4

Ejemplares similares